ATS 2024 Final Program

Click on the session title to view the speakers

308

TUESDAY • MAY 21

112 Association Between a Recalled Positive Airway Pressure Device and Incident Cancer: A Population-based Study 113 Improving Continuous Positive Airway Pressure Therapy in Stroke Patients Through Stakeholder Engagement Using a Human-centered Design Framework

CLINICAL • TRANSLATIONAL POSTER DISCUSSION SESSION

C109 PAP THERAPY CHRONICLES: THE ART OF RESTFUL NIGHTS 2:15 p.m. - 4:15 p.m. Marriott Marquis San Diego Marina Pacific Ballroom 15-17 (Ground Floor, North Tower) Poster Viewing 2:15-3:00 Discussion 3:00-4:15 101 Cardiometabolic Impacts of CPAP Withdrawal: Results of a Randomized Cross-over Study 102 Cardiovascular Effects of Positive Airway Pressure Withdrawal 103 Treatment of Sleep-disordered Breathing With Adaptive Servo-ventilation (READ-ASV) - Outcomes in Patients With Treatment-emergent Central Sleep Apnea (TE-CSA) in an European Registry 104 The Impact of Weight Change on Positive Airway Pressure Use in Patients With Obstructive Sleep Apnea and Obesity 105 Real-World Glucagon-like Peptide-1 (GLP-1) Adherence in Patients With Treated Obstructive Sleep Apnea 106 Electrical Consumption of Positive Airway Pressure Devices: Data From a Large National Cohort 107 Longitudinal PAP Adherence in Patients With Down Syndrome Using Cloud-based Data 108 Continuous Positive Airway Exposure in Patients With Obstructive Sleep Apnea Is Associated With Decreased Probability of Obstruction, A Measure of Upper Airway Patency 109 Less REM Sleep Predicts Mortality in Adults With Coronary Artery Disease and Obstructive Sleep Apnea: The RICCADSA Trial 110 Impact of Obstructive Sleep Apnea (OSA) Clinical and Polysomnographic Phenotypic Traits on Continuous Positive Airway Pressure (CPAP) Termination Rates: A 5-year Follow-up Study 111 The Effect of CPAP on Respiratory Load and Breathing Difficulty in the Healthy and Patients With OSA

CLINICAL • TRANSLATIONAL POSTER DISCUSSION SESSION

C110 SURFING THE INNOVATION WAVE IN SAN DIEGO: CUTTING-EDGE LUNG CANCER BIOMARKERS, DIAGNOSTICS AND TREATMENTS 2:15 p.m. - 4:15 p.m. San Diego Convention Center Room 5A-B (Upper Level) Poster Viewing 2:15-3:00 Discussion 3:00-4:15 601 Longitudinal Trend of a Radiomic Lung Cancer Prediction Score for Sub-solid Nodules 602 The Radiomic “Stress Test”: Validation of a Convolutional Neural Network Model in Patients With Clinically Challenging Indeterminate Pulmonary Nodules 603 Leveraging Radiomics in Concept Bottleneck Network for Pulmonary Nodule Classification 604 Biomarker Testing Practices for Non-small Cell Lung Cancer: A Survey of Veterans Affairs Facilities 605 Testing of Validated Radiomic Models Using a Challenging Cohort of Indeterminate Pulmonary Nodules (IPNs) 606 Novel Approach to Directly Sample Lung-Specific Volatile Organic Compounds in Exhaled Breath 607 To Evaluate a Proprietary Breath Analyzer in the Evaluation of High-risk Lung Nodules for Non-small Cell Lung Cancer: Single-center Feasibility Study 608 Evaluation of Change in Diagnostic Practices for Diagnosis of Lung Cancer With Implementation of Robotic-assisted Bronchoscopy

ATS 2024 Conference Program • San Diego, CA